QIAGEN announces winners of 2018 Microbiome Awards competition

QIAGEN’s next-generation QIAstat-Dx system delivers fast, cost-effective diagnosis of gastrointestinal syndromes

QIAGEN launches novel RNA-seq library preparation solutions for next-generation sequencing

QIAGEN applauds bold UN plan for tuberculosis prevention and care

QIAGEN receives FDA approval to expand use of EGFR test in lung cancer

QIAGEN and DiaSorin launch automated testing for latent TB infection with QuantiFERON-TB Gold Plus technology on widely used LIAISON platforms 

QIAGEN and NeuMoDx announce strategic partnership to offer next-generation systems for fully integrated molecular diagnostic testing

QIAGEN to join Germany’s MDAX index in addition to TecDAX

Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase

QIAGEN partners with The Scientific Group to expand commercial presence in Africa